Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Tempest Therapeutics, Inc. (OVAS)
|
|
| Operating Efficiency |
|
|
|
|
Annual |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| Turnover Ratios |
| Asset turnover | 0.0 | 0.0 | 0.0 | 1.1 | 0.7 | 0.0 | 0.0 | 0.0 |
| |
| Returns on Capital |
| ROIC (excluding intangibles) | -528.1% | -940.9% | -761.9% | 1117.1% | 97.9% | -79.2% | -98.5% | -106.3% |
| ROIC (including intangibles) | -378.8% | -679.0% | -1095.2% | 1374.1% | 557.4% | -93.0% | -112.1% | -83.5% |
| ROE | -191.3% | -74.7% | -107.7% | 75.8% | 36.8% | -72.5% | -70.0% | -56.8% |
| ROA | -75.2% | -36.8% | -84.4% | 60.6% | 32.0% | -64.0% | -61.9% | -52.0% |
| |
| Cash Conversion Cycle |
| Days sales outstanding | | | | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Days payables outstanding | | | | | | 1,035.9 | 147.5 | 544.0 |
| Cash conversion cycle | | | | | | -1,035.9 | -147.5 | -544.0 |
|